Alpha Tau Medical (DRTS) Non Operating Income (2021 - 2026)
Alpha Tau Medical's (DRTS) quarterly Non Operating Income came in at $9.6 million in Q1 2026, up 1445.95% year-on-year from $623370.9 in Q1 2025, and up 2335.96% quarter-over-quarter from -$431000.0 in Q4 2025.
Alpha Tau Medical (DRTS) Non Operating Income (2021 - 2026) Analysis & Trends
Alpha Tau Medical has disclosed Non Operating Income across 6 years of filings, most recently posting $9.6 million for Q1 2026.
- Non Operating Income for Q1 2026 came in at $9.6 million, up 1445.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 million (up 331.31% YoY), and the FY2025 annual result was $218000.0, up 105.07% from the prior year.
- Non Operating Income came in at $9.6 million for Q1 2026 at Alpha Tau Medical, up from -$431000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $17.0 million in Q1 2022 to a low of -$6.0 million in Q2 2022.
- The 5-year median for Non Operating Income is -$716000.0 (2025), against an average of $36705.9.
- Across the five-year window, Non Operating Income tumbled 3002.7% in 2022 and surged 1445.95% in 2026, its largest moves.
- Alpha Tau Medical's Non Operating Income stood at -$4.6 million in 2022, then jumped by 43.68% to -$2.6 million in 2023, then soared by 69.06% to -$800000.0 in 2024, then surged by 46.12% to -$431000.0 in 2025, then jumped by 2335.96% to $9.6 million in 2026.
- The last three Non Operating Income figures came in at $9.6 million (Q1 2026), -$431000.0 (Q4 2025), and $964000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | 9.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64 Mn |
| Dec 31, 2025 | -431,000.00 |
| Sep 30, 2025 | 964,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | -800,000.00 |
| Sep 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -444,000.00 |
| Dec 31, 2023 | -2.59 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | 499,000.00 |
| Mar 31, 2023 | -478,000.00 |
| Dec 31, 2022 | -4.59 Mn |
| Sep 30, 2022 | -4.74 Mn |
| Jun 30, 2022 | -6.02 Mn |
| Mar 31, 2022 | 16.96 Mn |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 3.49 Mn |